Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
D000661:Amphetamine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D002188:Cannabis / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003042:Cocaine / Q000494:pharmacology; D003496:Cyclazocine / Q000494:pharmacology; D004361:Drug Tolerance; D005059:Euphoria / Q000209:etiology; D006801:Humans; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D011680:Pupil / Q000187:drug effects; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders
D000700:Analgesics; D001463:Barbiturates; D009292:Narcotic Antagonists; D009020:Morphine; D000661:Amphetamine; D003042:Cocaine; D003496:Cyclazocine; D009269:Nalorphine